RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $189,530,626 | +38.5% | 8,267,421 | -0.4% | 0.16% | +40.4% |
Q2 2023 | $136,855,737 | +0.8% | 8,299,317 | +9.1% | 0.11% | -3.4% |
Q1 2023 | $135,714,428 | -32.6% | 7,607,311 | +10.1% | 0.12% | -35.9% |
Q4 2022 | $201,252,455 | +16.9% | 6,911,142 | -1.6% | 0.18% | +10.2% |
Q3 2022 | $172,159,000 | +551.8% | 7,026,892 | +10.4% | 0.17% | +595.8% |
Q2 2022 | $26,411,000 | -63.6% | 6,364,094 | +1.1% | 0.02% | -56.4% |
Q1 2022 | $72,484,000 | +16.1% | 6,291,991 | +0.6% | 0.06% | +27.9% |
Q4 2021 | $62,445,000 | -22.6% | 6,256,991 | +1.2% | 0.04% | -24.6% |
Q3 2021 | $80,725,000 | -33.0% | 6,181,091 | +0.4% | 0.06% | -29.6% |
Q2 2021 | $120,489,000 | -5.7% | 6,153,691 | +2.5% | 0.08% | -9.0% |
Q1 2021 | $127,739,000 | -1.1% | 6,005,593 | +38.3% | 0.09% | -7.3% |
Q4 2020 | $129,102,000 | +66.7% | 4,342,491 | +21.5% | 0.10% | +50.0% |
Q3 2020 | $77,464,000 | -2.0% | 3,574,691 | +0.8% | 0.06% | -5.9% |
Q2 2020 | $79,049,000 | +46.6% | 3,544,791 | +0.1% | 0.07% | +28.3% |
Q1 2020 | $53,918,000 | +12.2% | 3,542,591 | +69.2% | 0.05% | +51.4% |
Q4 2019 | $48,071,000 | +801.6% | 2,093,691 | +747.7% | 0.04% | +775.0% |
Q3 2019 | $5,332,000 | – | 246,977 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |